GRI
GRI Bio Inc.
NASDAQ: GRI · HEALTHCARE · BIOTECHNOLOGY
$2.18
-2.25% today
Updated 2026-04-30
Market cap
$3.41M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-121.80
Dividend yield
—
52W range
$2 – $80
Volume
0.1M
GRI Bio Inc. (GRI) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-238.20%
ROA
-103.90%
Debt/equity
0.01x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | — | $-4.31M | — | — | — |
| 2019 | — | $-3.46M | — | — | — |
| 2020 | $100000.00 | $-2.53M | 100.00% | -1,459.00% | -2,531.00% |
| 2021 | $0.00 | $-9.30M | — | — | — |
| 2022 | $0.00 | $-3.22M | — | — | — |
| 2023 | $21.77M | $-13.04M | -0.26% | -52.31% | -59.89% |
| 2024 | $22.54M | $-8.21M | -0.02% | -36.54% | -36.41% |
| 2025 | $0.00 | $-11.96M | — | — | — |